Free Trial

AC Immune (ACIU) Short Interest Ratio & Short Volume

AC Immune logo
$3.19 -0.36 (-10.14%)
(As of 11/15/2024 ET)

AC Immune Short Interest Data

AC Immune (ACIU) has a short interest of 984,500 shares, representing 1.59% of the float (the number of shares available for trading by the public). This marks a 23.54% increase in short interest from the previous month. The short interest ratio (days to cover) is 10.7, indicating that it would take 10.7 days of the average trading volume of 134,480 shares to cover all short positions.

Current Short Interest
984,500 shares
Previous Short Interest
796,900 shares
Change Vs. Previous Month
+23.54%
Dollar Volume Sold Short
$2.80 million
Short Interest Ratio
10.7 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
98,940,000 shares
Float Size
61,760,000 shares
Short Percent of Float
1.59%
Today's Trading Volume
234,162 shares
Average Trading Volume
134,480 shares
Today's Volume Vs. Average
174%
Short Selling AC Immune?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for AC Immune and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ACIU Short Interest Over Time

ACIU Days to Cover Over Time

ACIU Percentage of Float Shorted Over Time

AC Immune Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024984,500 shares $2.80 million +23.5%1.6%10.7 $2.84
10/15/2024796,900 shares $2.55 million -7.4%1.3%6.7 $3.20
9/30/2024860,900 shares $3.25 million +12.9%1.4%6.8 $3.78
9/15/2024762,400 shares $2.42 million +0.9%1.2%4.6 $3.18
8/31/2024756,000 shares $2.44 million -3.6%1.2%4.3 $3.23
8/15/2024784,000 shares $2.66 million -16.4%1.3%3.1 $3.39
7/31/2024938,300 shares $3.84 million -2.8%1.5%1.1 $4.09
7/15/2024964,900 shares $3.56 million +32.0%1.7%1.2 $3.69
6/30/2024731,100 shares $2.92 million -8.8%1.3%0.9 $3.99
6/15/2024801,400 shares $3.41 million +2.9%1.4%0.9 $4.26
5/31/2024779,200 shares $3.62 million -51.6%1.4%0.9 $4.65
5/15/20241,610,000 shares $5.65 million +218.1%2.8%2.1 $3.51
4/30/2024506,200 shares $1.26 million -0.6%0.9%2.8 $2.48
4/15/2024509,400 shares $1.28 million -9.1%0.9%2.8 $2.52
3/31/2024560,600 shares $1.66 million -3.8%1.0%3.4 $2.96
3/15/2024583,000 shares $2.04 million -7.2%1.0%3.8 $3.50
2/29/2024628,000 shares $2.27 million -6.0%1.1%4.2 $3.62
2/15/2024668,100 shares $2.01 million +39.0%1.2%4.7 $3.01
1/31/2024480,600 shares $1.54 million -14.1%0.9%3.8 $3.21
1/15/2024559,300 shares $2.56 million -3.4%1.0%5.1 $4.57
12/31/2023579,200 shares $2.90 million +16.7%1.0%5.6 $5.00
12/15/2023496,400 shares $1.95 million -3.0%0.9%5.8 $3.92
11/30/2023511,700 shares $1.69 million -9.4%1.2%10.3 $3.31
11/15/2023564,900 shares $1.69 million +5.5%1.4%11.6 $3.00
10/31/2023535,300 shares $1.61 million +10.4%1.3%10.5 $3.00
10/15/2023485,100 shares $1.35 million +2.8%1.2%8.6 $2.78
9/30/2023472,100 shares $1.35 million +3.8%1.1%6.8 $2.85
9/15/2023455,000 shares $1.37 million +17.3%1.1%0.5 $3.02
8/31/2023388,000 shares $1.26 million -8.6%0.9%0.4 $3.25
8/15/2023424,600 shares $1.29 million -20.2%1.0%0.4 $3.03
7/31/2023532,000 shares $1.60 million -29.4%1.3%0.5 $3.00
7/15/2023753,300 shares $2.29 million -32.1%1.8%0.8 $3.04
6/30/20231,110,000 shares $3.28 million +375.4%2.7%1.1 $2.96
6/15/2023233,500 shares $455,325.00 -0.9%0.6%2.8 $1.95
5/31/2023235,700 shares $513,826.00 -7.9%0.6%3 $2.18
5/15/2023256,000 shares $537,600.00 +9.5%0.6%3.3 $2.10
4/30/2023233,800 shares $453,572.00 -14.6%0.6%2.3 $1.94
4/15/2023273,900 shares $613,536.00 -5.6%0.7%2.2 $2.24
3/31/2023290,200 shares $679,068.00 -1.7%0.7%2 $2.34
3/15/2023295,300 shares $679,190.00 +3.1%0.7%1.4 $2.30
Strange: Why is Amazon suddenly yielding 39.70%? (Ad)

Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%!

Click here to see this breakthrough before everyone else →
2/28/2023286,300 shares $655,627.00 -2.3%0.7%1.4 $2.29
2/15/2023293,000 shares $676,830.00 -7.5%0.7%1.4 $2.31
1/31/2023316,800 shares $785,664.00 +25.6%0.8%1.4 $2.48
1/15/2023252,200 shares $617,890.00 +3.7%0.6%1.5 $2.45
12/30/2022243,200 shares $496,128.00 -24.4%0.6%1.6 $2.04
12/15/2022321,700 shares $656,268.00 -4.3%0.7%2.5 $2.04
11/30/2022336,100 shares $857,055.00 -24.5%0.8%4.3 $2.55
11/15/2022445,100 shares $1.16 million -2.2%1.0%6.3 $2.61
10/31/2022455,100 shares $1.24 million -4.5%1.0%7.2 $2.73
10/15/2022476,500 shares $1.40 million -2.7%1.1%7.8 $2.93
9/30/2022489,600 shares $1.55 million +6.4%1.1%8.5 $3.16
9/15/2022460,300 shares $1.27 million +22.5%1.1%8.4 $2.75
8/31/2022375,700 shares $1.13 million -18.6%0.9%5.4 $3.02
8/15/2022461,300 shares $1.68 million +11.3%1.1%6.5 $3.64
7/31/2022414,300 shares $1.46 million -5.4%1.0%4.7 $3.52
7/15/2022437,700 shares $1.47 million -10.4%1.0%4.9 $3.36
6/30/2022488,500 shares $1.76 million +6.7%1.1%5.2 $3.61
6/15/2022458,000 shares $1.31 million -5.4%1.1%5 $2.86
5/31/2022484,100 shares $1.52 million -28.0%1.1%5.5 $3.14
5/15/2022672,400 shares $2.01 million -19.8%1.6%6.8 $2.99
4/30/2022838,300 shares $3.00 million -5.6%2.3%8.6 $3.58
4/15/2022888,200 shares $3.46 million +25.6%2.4%8.1 $3.89
3/31/2022707,200 shares $2.83 million -1.0%1.9%6 $4.00
3/15/2022714,100 shares $2.66 million -3.7%2.2%5.2 $3.73
2/28/2022741,600 shares $3.02 million +40.2%2.3%4.6 $4.07
2/15/2022529,000 shares $2.38 million -2.5%1.6%2.8 $4.50
1/31/2022542,500 shares $2.40 million -3.5%1.7%1.5 $4.42
1/15/2022562,400 shares $2.71 million +4.4%1.7%1.3 $4.82
12/31/2021538,800 shares $2.67 million +5.7%1.7%1.2 $4.95
12/15/2021509,700 shares $2.67 million +0.9%1.6%1.1 $5.23
11/30/2021505,300 shares $2.59 million -17.0%1.6%1 $5.13
11/15/2021608,900 shares $3.52 million -50.9%1.9%0.3 $5.78
10/29/20211,240,000 shares $7.99 million +15.9%3.8%0.6 $6.44
10/15/20211,070,000 shares $6.61 million -10.8%3.3%0.5 $6.18
9/30/20211,200,000 shares $8.05 million +6.2%3.7%0.6 $6.71
9/15/20211,130,000 shares $7.70 million +8.7%3.5%0.6 $6.81
8/31/20211,040,000 shares $8.46 million -11.1%3.2%0.5 $8.13
8/13/20211,170,000 shares $7.77 million -4.1%3.6%2.4 $6.64
7/30/20211,220,000 shares $8.88 million +0.8%3.8%2.5 $7.28
7/15/20211,210,000 shares $9.00 million +8.0%3.1%2.5 $7.44
6/30/20211,120,000 shares $8.88 million -13.2%2.8%2.3 $7.93
6/15/20211,290,000 shares $9.34 million +25.2%3.3%2.7 $7.24
5/28/20211,030,000 shares $6.27 million -14.2%2.6%2.3 $6.09
5/14/20211,200,000 shares $7.42 million -0.8%3.0%4.3 $6.18
4/30/20211,210,000 shares $8.28 million -7.6%3.1%1.5 $6.84
4/15/20211,310,000 shares $9.00 million -7.8%3.3%1.5 $6.87
3/31/20211,420,000 shares $10.42 million -6.0%3.6%1.5 $7.34
3/15/20211,510,000 shares $11.78 million +3.4%3.9%1.5 $7.80
2/26/20211,460,000 shares $11.18 million +25.9%3.8%1.5 $7.66
2/12/20211,160,000 shares $9.78 million +8.4%3.0%1.2 $8.43
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
1/29/20211,070,000 shares $6.56 million -13.0%2.8%3 $6.13
1/15/20211,230,000 shares $7.53 million -3.9%3.2%3.6 $6.12
12/31/20201,280,000 shares $6.57 million No Change3.3%3.7 $5.13
12/15/20201,280,000 shares $6.37 million -12.9%3.3%3.7 $4.98
11/30/20201,470,000 shares $8.19 million -11.5%3.8%3.6 $5.57
11/15/20201,660,000 shares $8.53 million -11.2%4.3%4.1 $5.14
10/30/20201,870,000 shares $8.90 million +1.6%4.9%4.4 $4.76
10/15/20201,840,000 shares $9.13 million -7.5%4.8%4.3 $4.96
9/30/20201,990,000 shares $9.71 million +20.6%5.2%1.7 $4.88
9/15/20201,650,000 shares $14.95 million +7.1%4.3%1.5 $9.06
8/31/20201,540,000 shares $11.95 million -0.7%4.0%1.6 $7.76
8/14/20201,550,000 shares $10.65 million +46.2%4.0%1.6 $6.87
7/31/20201,060,000 shares $6.92 million +71.4%2.8%1.2 $6.53
7/15/2020618,400 shares $4.41 million -1.4%1.6%0.7 $7.13
6/30/2020627,100 shares $4.22 million +1.8%1.6%7.4 $6.73
6/15/2020616,200 shares $4.21 million -7.6%1.6%5.7 $6.84
5/29/2020666,900 shares $5.16 million +11.4%1.8%5.4 $7.74
5/15/2020598,600 shares $4.26 million +1.3%1.6%4.7 $7.11
4/30/2020590,700 shares $4.20 million +1.3%1.6%4.1 $7.11
4/15/2020583,100 shares $4.22 million +8.0%1.6%3.8 $7.24
3/31/2020540,100 shares $4.27 million +39.6%1.5%3.2 $7.90
3/13/2020386,900 shares $2.70 million +6.0%1.2%3.3 $6.98
2/28/2020365,000 shares $1.96 million +18.1%1.1%2.3 $5.38
2/14/2020309,200 shares $1.89 million -30.8%0.9%1.9 $6.12
1/31/2020446,600 shares $3.26 million -1.4%1.3%2.9 $7.31
1/15/2020452,700 shares $3.91 million +11.5%1.4%3.4 $8.63
12/31/2019406,200 shares $3.51 million -6.0%1.2%3.2 $8.64

ACIU Short Interest - Frequently Asked Questions

What is AC Immune's current short interest?

Short interest is the volume of AC Immune shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 984,500 shares of ACIU short. 1.59% of AC Immune's shares are currently sold short. Learn More on AC Immune's current short interest.

What is a good short interest ratio for AC Immune?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACIU shares currently have a short interest ratio of 11.0. Learn More on AC Immune's short interest ratio.

What is a good short interest percentage for AC Immune?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.59% of AC Immune's floating shares are currently sold short.

Is AC Immune's short interest increasing or decreasing?

AC Immune saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 984,500 shares, an increase of 23.5% from the previous total of 796,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is AC Immune's float size?

AC Immune currently has issued a total of 98,940,000 shares. Some of AC Immune's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AC Immune currently has a public float of 61,760,000 shares.

How does AC Immune's short interest compare to its competitors?

1.59% of AC Immune's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to AC Immune: Arcutis Biotherapeutics, Inc. (23.72%), Ardelyx, Inc. (10.16%), Calliditas Therapeutics AB (publ) (0.01%), Bicycle Therapeutics plc (6.88%), Applied Therapeutics, Inc. (10.43%), ArriVent BioPharma, Inc. (18.26%), Cogent Biosciences, Inc. (7.70%), Immatics (5.60%), Collegium Pharmaceutical, Inc. (19.87%), 89bio, Inc. (5.07%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short AC Immune stock?

Short selling ACIU is an investing strategy that aims to generate trading profit from AC Immune as its price is falling. ACIU shares are trading down $0.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AC Immune?

A short squeeze for AC Immune occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACIU, which in turn drives the price of the stock up even further.

How often is AC Immune's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACIU, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:ACIU) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners